Professor David Price

Professor David Price
Professor David Price
Professor David Price

Chair of Primary Care Respiratory Med

About
Publications

Page 19 of 86 Results 181 to 190 of 857

  • Use of the oral beta blocker bisoprolol to reduce the rate of exacerbation in people with chronic obstructive pulmonary disease (COPD): a randomised controlled trial. (BICS)

    Cotton, S., Devereux, G., Abbas, H., Briggs, A. H., Campbell, K., Chaudhuri, R., Choudhury, G., Dawson, D., De Soyza, A., Fielding, S., Gompertz, S., Haughney, J., Lang, C. C., Lee, A., MacLennan, G., MacNee, W., McCormack, K., McMeekin, N., Mills, N. L., Morice, A., Norrie, J., Petrie, L., Price, D., Short, P., Vestbo, J., Walker, P., Wedzicha, J. A., Wilson, A., Lipworth, B. J.
    Trials, vol. 23, no. 1, 307
    Contributions to Journals: Articles
  • Asthma exacerbation and steroid burden in Australian primary care

    Price, D., Hancock, K. L., Bosnic-Anticevich, S., Blakey, J., Hew, M., Chung, L. P., Cvetkovski, B., Claxton, S., Del Fante, P., Denton, E., Doan, J., Ranasinghe, K., Morgan, L., Sharma, A., Smith, P. K., Feldman-Stewart, D., Thompson, P., Wiseman, R., Upham, J. W., Yan, K. Y., Carter, V., Dhillon, K., Heraud, F., Le, T., Vella, R., OPCA Improving Asthma outcomes in Australia Research Group
    The Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science 2022, pp. 194
    Contributions to Journals: Abstracts
  • No difference in pneumonia risk in COPD patients initiating fixed dose combination (FDC) inhaler comprising extrafine beclometasone dipropionate versus long-acting bronchodilators

    Price, D., Henley, W., Carter, V., Skinner, D., Vella, R., Papi, A., Fabbri, L. M., Kertsjens, H., Roche, N., Singh, D., Vogelmeier, C., Sen, E., Cancado, J., Nudo, E., Barile, S., Georges, G.
    TSANZSRS 2022, pp. 28-29
    Contributions to Journals: Abstracts
  • A pooled analysis of mortality in patients with COPD receiving dual bronchodilation with and without additional inhaled corticosteroid

    Miravitlles, M., Verhamme, K. M., Calverley, P. M. A., Dreher, M., Bayer, V., Gardev, A., de la Hoz, A., Wedzicha, J. A., Price, D.
    International journal of chronic obstructive pulmonary disease , vol. 2022, no. 17, pp. 545—558
    Contributions to Journals: Articles
  • The burden of intermittent oral corticosteroid use in asthma

    Heatley, H., Tran, T. N., Bourdin, A., Menzies-Gow, A., Jackson, D. J., Maslova, E., Chapaneri, J., Skinner, D., Carter, V., Shi Kai Chan, J., Ariti, C., Haughney, J., Price, D.
    IPCRG 2022
    Contributions to Conferences: Abstracts
  • Lower pneumonia risk in COPD patients initiating fixed dose combination (FDC) inhaler comprising extrafine beclometasone dipropionate versus fluticasone

    Price, D., Henley, W., Carter, V., Skinner, D., Vella, R., Papi, A., Fabbri, L. M., Kertsjens, H., Roche, N., Singh, D., Vogelmeier, C., Sen, E., Cancado, J., Nudo, E., Barile, S., Georges, G.
    The Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science 2022, pp. 81
    Contributions to Journals: Abstracts
  • CONQUEST: a quality improvement program for defining and optimizing standards of care for modifiable high-risk COPD patients

    Alves, L., Pullen, R., Hurst, J. R., Miravitlles, M., Carter, V., Chen, R., Couper, A., Dransfield, M., Evans, A., Hardjojo, A., Jones, D., Jones, R., Kerr, M., Kostikas, K., Marshall, J., Martinez, F. J., van Melle, M., van Melle, M., Murray, R. B., Muro, S., Nordon, C., Pollack, M., Price, C., Sharma, A., Singh, D., Winders, T. A., Price, D.
    Patient Related Outcome Measures, vol. 2022, no. 13, pp. 53-68
    Contributions to Journals: Articles
  • Interclass difference in pneumonia risk in COPD patients initiating fixed dose inhaled treatment containing extrafine particle beclometasone versus fine particle fluticasone

    Price, D., Henley, W., Delfini Cançado, J. E., Fabbri, L. M., Kerstjens, H. A., Papi, A., Roche, N., Şen, E., Singh, D., Vogelmeier, C., Barille, S., Nudo, E., Carter, V., Skinner, D., Vella, R., Georges, G.
    International journal of chronic obstructive pulmonary disease , vol. 2022, no. 17, pp. 355—370
    Contributions to Journals: Articles
  • Ethnic differences in severe asthma clinical care and outcomes: an analysis of United Kingdom primary and specialist care

    Busby, J., Heaney, L. G., Brown, T., Chaudhuri, R., Dennison, P., Gore, R., Jackson, D. J., Mansur, A. H., Menzies-Gow, A., Message, S., Niven, R., Patel, M., Price, D., Siddiqui, S., Stone, R. A., Pfeffer, P. E., UK Severe Asthma Registry
    The Journal of Allergy and Clinical Immunology: In Practice, vol. 10, no. 2, pp. 495-505
    Contributions to Journals: Articles
  • Treatment Trials in Young Patients with Chronic Obstructive Pulmonary Disease and Pre-Chronic Obstructive Pulmonary Disease Patients: Time to move forward

    Martinez, F. J., Agusti, A., Celli, B. R., Han, M. K., Allinson, J., Bhatt, S. P., Calverley, P., Chotirmall, S. H., Chowdhury, B., Darken, P., Da Silva, C. A., Donaldson, G., Dorinsky, P., Dransfield, M., Faner, R., Halpin, D. M., Jones, P., Krishnan, J. A., Locantore, N., Martinez, F. D., Müllerová, H., Price, D., Rabe, K. F., Reisner, C., Singh, D., Vestbo, J., Vogelmeier, C. F., Wise, R. A., Tal-Singer, R., Wedzicha, J. A.
    American Journal of Respiratory and Critical Care Medicine, vol. 205, no. 3, pp. 275-287
    Contributions to Journals: Articles
Show 10 | 25 | 50 | 100 results per page

Refine

Chapters in Books, Reports and Conference Proceedings

Contributions to Conferences

Contributions to Journals

Contributions to Specialist Publications

Working Papers

Other Contributions